http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22153002

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article
endingPage 9
issn 1791-7530
issueIdentifier 12
pageRange 4553-9
publicationName Anticancer research
startingPage 4553
bibliographicCitation Vitale FV, Romeo P, DI Maggio EM, Parisi A, Malaponte E, Calì S, Vasta F, Panebianco V, Arcoria D, Ferraù F. Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors. Anticancer Res. 2011 Dec;31(12):4553–9. PMID: 22199330.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dc3b0fb00405902b8379cc66d29bd40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81778106b1f29bf044dd84ee3e5944ea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0636be401dca94621d9ed8137979f08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_988a659951f357c99d81e87af4288ace
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59b619840e718c28a2ecf77c7cc20125
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09d54936b53153fc2515309e9c71206b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_548847ab9c3d69071a47a316657f3df6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbe1f92cec8f2e8f8c01e193d7c480cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_443b052b6835d4f6d3ad049c9dd5a123
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2a87cad3eca8bee41da0b396f2ddee9
date 201112
identifier https://pubmed.ncbi.nlm.nih.gov/22199330
isPartOf https://portal.issn.org/resource/ISSN/1791-7530
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/592
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors
discusses http://id.nlm.nih.gov/mesh/M0015421
http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0153576
http://id.nlm.nih.gov/mesh/M0552528
http://id.nlm.nih.gov/mesh/M0025711
http://id.nlm.nih.gov/mesh/M0014925
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008113Q000188
http://id.nlm.nih.gov/mesh/D009943Q000008
http://id.nlm.nih.gov/mesh/D016898Q000008
http://id.nlm.nih.gov/mesh/D009607Q000008
http://id.nlm.nih.gov/mesh/D007261Q000379
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D008099Q000098
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011994Q000008
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000077190
http://id.nlm.nih.gov/mesh/D014057Q000379
http://id.nlm.nih.gov/mesh/D008495Q000379
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D001706
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104799
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c73966f4f68c5cfd75b54c0b1fd40f70
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7039

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490

Total number of triples: 57.